Aethlon Medical grants Chief Medical Officer Steven LaRosa 42,000 restricted stock units
AEMD•Aethlon Medical awarded Chief Medical Officer Steven P. LaRosa 42,000 shares of common stock on October 8, 2026.
AEMD•Aethlon Medical awarded Chief Medical Officer Steven P. LaRosa 42,000 shares of common stock on October 8, 2026.
Aethlon Medical awarded Chief Medical Officer Steven P. LaRosa 42,000 shares of common stock on October 8, 2026.